000 05423cam a2200421Mi 4500
001 96610
003 ES-MaUEC
005 20230102112802.0
006 m o d
007 cr |n|||||||||
008 171017s2017 si o 000 0 eng d
020 _a9789811036477
_q(electronic bk.)
020 _a9811036470
_q(electronic bk.)
020 _z9789811036460
020 _z9811036462
040 _aYDX
_beng
_epn
_cYDX
_dN$T
_dGW5XE
_dEBLCP
_dN$T
_dOCLCF
_dUAB
_dDKU
_dAZU
_dUPM
_dIOG
_dJG0
_dCOO
_dOCLCQ
_dES-MaUEC
_bspa
050 4 _aRS201.N35
_b2017 EB
245 0 0 _aParticulate technology for delivery of therapeutics
_cSougata Jana, Subrata Jana, editors.
264 1 _aSingapore
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
500 _a
_bSpringer Biomedical and Life Sciences eBooks 2017 English+International
505 0 _a""Preface""; ""Contents""; ""About the Editors""; ""List of Contributors""; ""1 Introduction to Novel Therapeutic Carriers""; ""Abstract""; ""1 Introduction""; ""2 Type of New Drug Carriers Systems""; ""2.1 Transdermal Drug Delivery System""; ""2.2 Carrier-Based Delivery Systems""; ""2.3 Variable Release Delivery Systems""; ""2.3.1 Osmotic Pump-Based Drug Delivery Systems""; ""2.3.2 Reservoir-Based System""; ""2.3.3 Matrix-Based Drug Delivery System""; ""3 Preparation of Particulate Drug Delivery Systems""; ""3.1 Dispersion Method""; ""3.2 Solvent Evaporation Method""
505 8 _a""1.2 Rationale of Cancer Nanotechnology""""1.3 Important Considerations in Nanoparticle-Based Delivery for Cancer Treatment""; ""1.3.1 Passive Targeting of Nanoparticles: Enhanced Permeability and Retention (EPR) Effect""; ""1.3.2 Active Targeting of Nanoparticles""; ""2 Polymeric Nanocarriers for Therapeutic Applications in Cancer""; ""2.1 Polymeric Micelles for Therapeutic Applications in Cancer""; ""2.1.1 Doxorubicin (DOX) Conjugated Polymeric Micelles""; ""2.1.2 Paclitaxel (PTX) Conjugated Polymeric Micelles""; ""2.1.3 Other Chemotherapeutic Drugs Conjugated Polymeric Micelles""
505 8 _a""2.2 Polymeric Nanoparticles for Therapeutic Applications in Cancer""""2.2.1 PTX-Loaded Polymericnano Particles""; ""2.2.2 DOX-Loaded Polymeric Nanoparticles""; ""2.2.3 Other Chemotherapeutic Drugs Loaded Polymericnano Particles""; ""3 Stimuli-responsive Polymeric Nanocarriers""; ""3.1 Endogenous Stimuli-responsive Polymeric Nanoparticles and Micelles""; ""3.2 Exogenous Stimuli-Responsive Polymeric Nanoparticles and Micelles""; ""3.3 Multiple Stimuli-Responsive Polymeric Nanoparticles and Micelles""; ""4 Conclusions""; ""Acknowledgements""; ""References""
505 8 _a""3 Nanotechnology-Based Immunotherapeutic Strategies for the Treatment of Cancer""""Abstract""; ""1 Introduction""; ""2 Immunotherapies""; ""3 Cancer and Immune System""; ""3.1 Limitations of Existing Cancer Therapies""; ""4 Basics and Strategies of Cancer Immunotherapy""; ""4.1 Monoclonal Antibodies (mAbs)""; ""4.2 Cancer Vaccines""; ""4.3 Peptide Vaccines""; ""4.4 Tumor Cell Based Vaccines""; ""4.5 DNA Vaccines""; ""4.6 Vector-Based Vaccines""; ""4.7 Dendritic Cell Based Immunotherapy""; ""4.8 Immune Checkpoint Inhibitors""; ""4.9 Nonspecific Immunotherapies""; ""4.9.1 Nano-immunotherapy""
505 8 _a""3.3 Emulsification or Solvent Diffusion Method""""3.4 Coacervation Method""; ""3.5 Polymerization Method""; ""3.6 Spray Drying and Congealing""; ""3.7 Emulsification-Cross-Linking Method""; ""3.8 Reverse Micellar Method""; ""3.9 Supercritical Method""; ""4 Release Kinetics from Nondegradable Polymeric Matrices""; ""5 Release Kinetics from Biodegradable Polymeric Matrices""; ""6 Concluding Remarks""; ""References""; ""2 The Development and Achievement of Polymeric Nanoparticles for Cancer Drug Treatment""; ""Abstract""; ""1 Introduction""; ""1.1 Physiological Conditions of Tumor Tissues""
520 3 _aThe book focuses on novel particulate technologies for the purpose of drug delivery to humans. Nowadays, macro and nano-scale particles are being investigated for targeted delivery of small and large biological macromolecules. The targeting of drugs can minimize the dosage regimen and reduces dose related potential toxicity of drug molecules, which in turn lead to increased potential compliance. Various types of organic, inorganic and polymer particles are currently being investigated. These are attracting the attention of the research workers in the field of drug delivery science and technology. This book covers polymersomes, inorganic- organic composites, gold nanoparticles biopolymer and synthetic polymer particles etc. All aspects of drug delivery in relation to each technology have been described including these advances, Easy to read and understand the content of each chapter Rich in up-to-date information regarding their application.
650 7 _aPartículas (Física nuclear)
_2embne
_0(OCoLC)fst01032624
_0
_9137958
700 1 _aJana, Sougata.
700 1 _aJana, Subrata.
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-981-10-3647-7
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aEBOOK, asignarmaterias, EBSPRINGER_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c96610
_d96610
_x1